weight loss drugs glp-1 Do the new weight-loss improve your health? Overdose risks increase as demand
Description
The authors theorise that microdosing Wegovy could help to limit gastrointestinal side effects, which are particularly common during dose escalations
The control (C) comprised individuals who received either a placebo or another active comparator
Some patients use a maintenance plan for a few months, while others may need longer support depending on their goals, response to medication, and overall health
5 December 2017
